Cao Z[au] - Search Results

Year	Number of Results
1963	1
1981	4
1982	3
1983	3
1984	3
1985	6
1986	6
1987	9
1988	13
1989	14
1990	12
1991	9
1992	10
1993	21
1994	15
1995	15
1996	25
1997	40
1998	34
1999	25
2000	38
2001	51
2002	57
2003	76
2004	92
2005	97
2006	109
2007	130
2008	161
2009	195
2010	201
2011	201
2012	261
2013	318
2014	357
2015	420
2016	488
2017	493
2018	563
2019	723
2020	826
2021	380

1

Evasion of Type I Interferon by SARS-CoV-2.

Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY. Xia H, et al. Among authors: cao z. Cell Rep. 2020 Oct 6;33(1):108234. doi: 10.1016/j.celrep.2020.108234. Epub 2020 Sep 19. Cell Rep. 2020. PMID: 32979938 Free PMC article.

2

Point of view: Should COVID-19 patients be supplemented with vitamin D?

Annweiler C, Cao Z, Sabatier JM. Annweiler C, et al. Among authors: cao z. Maturitas. 2020 Oct;140:24-26. doi: 10.1016/j.maturitas.2020.06.003. Epub 2020 Jun 8. Maturitas. 2020. PMID: 32972631 Free PMC article. Review.

3

Myricetin: A review of the most recent research.

Song X, Tan L, Wang M, Ren C, Guo C, Yang B, Ren Y, Cao Z, Li Y, Pei J. Song X, et al. Among authors: cao z. Biomed Pharmacother. 2021 Feb;134:111017. doi: 10.1016/j.biopha.2020.111017. Epub 2020 Dec 15. Biomed Pharmacother. 2021. PMID: 33338751 Free article. Review.

4

Anti-inflammatory effects of cordycepin: A review.

Tan L, Song X, Ren Y, Wang M, Guo C, Guo D, Gu Y, Li Y, Cao Z, Deng Y. Tan L, et al. Among authors: cao z. Phytother Res. 2020 Oct 8. doi: 10.1002/ptr.6890. Online ahead of print. Phytother Res. 2020. PMID: 33090621 Review.

5

A Review of the Pharmacological Properties of Psoralen.

Ren Y, Song X, Tan L, Guo C, Wang M, Liu H, Cao Z, Li Y, Peng C. Ren Y, et al. Among authors: cao z. Front Pharmacol. 2020 Sep 4;11:571535. doi: 10.3389/fphar.2020.571535. eCollection 2020. Front Pharmacol. 2020. PMID: 33013413 Free PMC article. Review.

6

First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811.

Chung HC, Bang YJ, S Fuchs C, Qin SK, Satoh T, Shitara K, Tabernero J, Van Cutsem E, Alsina M, Cao ZA, Lu J, Bhagia P, Shih CS, Janjigian YY. Chung HC, et al. Among authors: cao za. Future Oncol. 2021 Feb;17(5):491-501. doi: 10.2217/fon-2020-0737. Epub 2020 Nov 10. Future Oncol. 2021. PMID: 33167735 Free article.

7

PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.

Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W, Hu J, Lu C, Liu Y. Liu R, et al. Among authors: cao z. Cell Death Dis. 2020 Sep 24;11(9):797. doi: 10.1038/s41419-020-02998-6. Cell Death Dis. 2020. PMID: 32973135 Free PMC article. Review.

8

An Antioxidant Enzyme Therapeutic for COVID-19.

Qin M, Cao Z, Wen J, Yu Q, Liu C, Wang F, Zhang J, Yang F, Li Y, Fishbein G, Yan S, Xu B, Hou Y, Ning Z, Nie K, Jiang N, Liu Z, Wu J, Yu Y, Li H, Zheng H, Li J, Jin W, Pang S, Wang S, Chen J, Gan Z, He Z, Lu Y. Qin M, et al. Among authors: cao z. Adv Mater. 2020 Oct;32(43):e2004901. doi: 10.1002/adma.202004901. Epub 2020 Sep 13. Adv Mater. 2020. PMID: 32924219

9

Aging Reprograms the Hematopoietic-Vascular Niche to Impede Regeneration and Promote Fibrosis.

Chen Y, Pu Q, Ma Y, Zhang H, Ye T, Zhao C, Huang X, Ren Y, Qiao L, Liu HM, Esmon CT, Ding BS, Cao Z. Chen Y, et al. Among authors: cao z. Cell Metab. 2021 Feb 2;33(2):395-410.e4. doi: 10.1016/j.cmet.2020.11.019. Epub 2020 Dec 22. Cell Metab. 2021. PMID: 33357457

10

A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.

Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, Pei P, Wang C, Wu H, Dong Z, Chao Y, Wang C, Yang K, Peng R, Cheng Y, Liu Z. Xu J, et al. Among authors: cao z. Nat Nanotechnol. 2020 Dec;15(12):1043-1052. doi: 10.1038/s41565-020-00781-4. Epub 2020 Nov 2. Nat Nanotechnol. 2020. PMID: 33139933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results